The short can still be held because META has not broken the decisive invalidation zone: price remains below 691.52 resistance and below the 695 stop area even after the rebound. Into a high-expectation earnings setup, the blocked Manus deal and broader regulatory/franchise questions can cap upside and produce a rejection that sends price back toward the mid-600s or lower before the horizon expires.
Continued AI infrastructure spending and recurring revenue growth validate the premium, leading to a price hold above support and resumption of trend toward target within the remaining 2-4 weeks
The original short thesis remains valid as technical structure shows price stalling near resistance with overbought momentum. Despite a minor move against the position, the reward-to-risk ratio remains highly favorable at 2.75:1, and the target is still well within reach if post-earnings weakness materializes. The $639.37 support level remains intact, providing a clear structural floor for the downside move.
No model argued for EXIT.
The short can still be held because META has not broken the decisive invalidation zone: price remains below 691.52 resistance and below the 695 stop area even after the rebound. Into a high-expectation earnings setup, the blocked Manus deal and broader regulatory/franchise questions can cap upside and produce a rejection that sends price back toward the mid-600s or lower before the horizon expires.
The short can still be held because META has not broken the decisive invalidation zone: price remains below 691.52 resistance and below the 695 stop area even after the rebound. Into a high-expectation earnings setup, the blocked Manus deal and broader regulatory/franchise questions can cap upside and produce a rejection that sends price back toward the mid-600s or lower before the horizon expires.
▼ Click to expandThe position should be closed if you believe the market is already telling you the bearish thesis is wrong: META is above the 4h and daily trend averages, RSI is rising, and sector confirmation from XLC suggests buyers still control the tape. With earnings due tomorrow, a positive report could gap the stock straight through resistance and the stop before the trade has time to recover.
▼ Click to expandThe original short thesis remains valid as technical structure shows price stalling near resistance with overbought momentum. Despite a minor move against the position, the reward-to-risk ratio remains highly favorable at 2.75:1, and the target is still well within reach if post-earnings weakness materializes. The $639.37 support level remains intact, providing a clear structural floor for the downside move.
The original short thesis remains valid as technical structure shows price stalling near resistance with overbought momentum. Despite a minor move against the position, the reward-to-risk ratio remains highly favorable at 2.75:1, and the target is still well within reach if post-earnings weakness materializes. The $639.37 support level remains intact, providing a clear structural floor for the downside move.
▼ Click to expandThe position has moved slightly against the entry, and a near-term earnings-driven short squeeze could push price to the $695 stop. Analysts have high expectations for Q1 results, and any beat on the $6.67 EPS consensus could trigger a sharp upward move, invalidating the bearish setup. Additionally, the baseline bias has weakened from long to neutral, reducing conviction in a reversal.
▼ Click to expandContinued AI infrastructure spending and recurring revenue growth validate the premium, leading to a price hold above support and resumption of trend toward target within the remaining 2-4 weeks
Continued AI infrastructure spending and recurring revenue growth validate the premium, leading to a price hold above support and resumption of trend toward target within the remaining 2-4 weeks
▼ Click to expandIntraday discovery triggered reanalysis on META. Verdict: HOLD (0/3 EXIT). Conviction: 30.